CircUHRF1 is also implicated to confer resistance to anti-PD-1/PD-L1 therapy, as demonstrated by the increased sensitivity of circUHRF-1-knockdown HCC cells to anti-PD-1/PD-L1 treatment (Zhang P.-F. This evidence concerns the gene CD274 and hepatocellular carcinoma.